PREVIEW
OF YOUR NEWS WIDGETArthritis news and arthritis widget
Friday, October 31, 2008 ( change date )
Rituxan Data In Patients With Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology Annual Scientific Meeting
Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) announced that Rituxan®: (rituximab) data including results from Phase II and III studies of Rituxan in patients with moderately-to-severely active rheumatoid arthritis (RA) will be featured in two podium presentations and eight poster presentations at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco this week.
Medicalnewstoday.com Friday, October 31, 2008Nearly 10% of U.S. Adults Sought Arthritis Treatment in 2005
Approximately 9.5% of noninstitutionalized American adults (18 years and older) either visited or called a doctor to get a prescription to reduce arthritis pain in 2005 (the latest year of...
z.about.com Friday, October 31, 2008RA Diagnosis Doubles Heart Attack Odds
Title: RA Diagnosis Doubles Heart Attack OddsCategory: health newscreated: 10/31/2008Last Editorial review: 10/31/2008
medicinenet.com Friday, October 31, 2008
INSTALL YOUR WIDGET